TXMD TherapeuticsMD, Inc. Stock Quote

TXMD [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-21.74	Insider Own	0.10%	Shs Outstand	424.93M	Perf Week	-10.29%
Market Cap	13.84M	Forward P/E	-	EPS next Y	-1.17	Insider Trans	-82.43%	Shs Float	380.53M	Perf Month	-80.56%
Income	-182.10M	PEG	-	EPS next Q	-2.40	Inst Own	29.70%	Short Float	0.39%	Perf Quarter	-78.67%
Sales	86.40M	P/S	0.16	EPS this Y	34.90%	Inst Trans	-15.77%	Short Ratio	2.15	Perf Half Y	-92.45%
Book/sh	-16.32	P/B	-	EPS next Y	80.90%	ROA	-100.70%	Target Price	63.00	Perf Year	-96.46%
Cash/sh	4.79	P/C	0.46	EPS next 5Y	17.60%	ROE	213.80%	52W Range	2.05 - 69.50	Perf YTD	-87.74%
Dividend	-	P/FCF	-	EPS past 5Y	1.10%	ROI	-147.60%	52W High	-96.86%	Beta	2.38
Dividend %	-	Quick Ratio	0.30	Sales past 5Y	35.00%	Gross Margin	78.00%	52W Low	6.34%	ATR	0.89
Employees	416	Current Ratio	0.30	Sales Q/Q	-3.00%	Oper. Margin	-	RSI (14)	19.51	Volatility	21.14% 19.83%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-0.30%	Profit Margin	-	Rel Volume	0.84	Prev Close	2.15
Shortable	No	LT Debt/Eq	-	Earnings	May 16 AMC	Payout	-	Avg Volume	683.09K	Price	2.18
Recom	2.50	SMA20	-61.40%	SMA50	-82.52%	SMA200	-90.71%	Volume	574,215	Change	1.40%

Aug-07-20

Downgrade

Jefferies

Hold → Underperform

May-19-20

Downgrade

JP Morgan

Overweight → Neutral

Dec-02-19

Initiated

Guggenheim

Buy

Oct-17-19

Initiated

H.C. Wainwright

Buy

Apr-30-19

Resumed

Noble Capital Markets

Outperform

$13

Jun-15-18

Initiated

JP Morgan

Overweight

$11

Sep-08-17

Initiated

Morgan Stanley

Equal-Weight

Jul-11-17

Upgrade

Oppenheimer

Perform → Outperform

May-09-17

Downgrade

Oppenheimer

Outperform → Perform

Nov-22-16

Resumed

Jefferies

Buy

$18

Nov-22-16

Initiated

Oppenheimer

Outperform

Nov-07-16

Resumed

Guggenheim

Buy

Apr-04-16

Initiated

Goldman

Buy

$10

Dec-08-15

Reiterated

Stifel

Buy

$10 → $14

Dec-08-15

Reiterated

Jefferies

Buy

$15 → $18

Sep-21-15

Reiterated

Jefferies

Buy

$7 → $15

Jun-09-15

Initiated

Guggenheim

Buy

Jul-08-14

Initiated

FBR Capital

Outperform

$34

Apr-17-14

Reiterated

Noble Financial

Buy

$9 → $13

Jan-28-14

Reiterated

Noble Financial

Buy

$7.25 → $9

May-20-22 10:52AM	Why TherapeuticsMD Shares Are Trading Higher Today Benzinga +36.56%
09:43AM	TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA) for ANNOVERA® Business Wire
May-16-22 08:00PM	TherapeuticsMD, Inc. (TXMD) Q1 2022 Earnings Call Transcript Motley Fool
05:45PM	TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates Zacks
04:05PM	TherapeuticsMD Announces First Quarter 2022 Financial Results Business Wire
May-12-22 05:25PM	Harpoon Therapeutics, Inc. (HARP) Reports Q1 Loss, Misses Revenue Estimates Zacks -13.87%
May-10-22 04:05PM	TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022 Business Wire
Apr-14-22 04:15PM	TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million Business Wire
Mar-10-22 01:30PM	TherapeuticsMD, Inc. (TXMD) Q4 2021 Earnings Call Transcript Motley Fool -27.50%
08:05AM	TherapeuticsMD (TXMD) Reports Q4 Loss, Lags Revenue Estimates Zacks
06:50AM	TherapeuticsMD Announces Fourth Quarter 2021 Financial Results Business Wire
Mar-07-22 12:57PM	TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal Benzinga +43.05%
07:40AM	TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx Business Wire
Mar-01-22 04:30PM	TherapeuticsMD to Report Fourth Quarter 2021 Financial Results on March 10, 2022 Business Wire -5.69%
Feb-28-22 05:35PM	Nektar Therapeutics (NKTR) Reports Q4 Loss, Lags Revenue Estimates Zacks +8.28%
Feb-24-22 09:05AM	Radius Health (RDUS) Reports Q4 Loss, Tops Revenue Estimates Zacks
Jan-25-22 08:52AM	TherapeuticsMD, Inc. (NASDAQ:TXMD): Is Breakeven Near? Simply Wall St.
Jan-06-22 07:29AM	Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday InvestorPlace
Jan-04-22 06:20AM	FDA Approves TherapeuticsMD's Low Dose Bijuva Benzinga +11.18%
Dec-28-21 09:53AM	Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options Zacks
Dec-13-21 06:08AM	TherapeuticsMD's Birth Control Med Receives FDA Response Letter To Revise Manufacturing Testing Limits Benzinga -11.51%
Dec-10-21 04:30PM	U.S. Food and Drug Administration (FDA) Responds to Request From TherapeuticsMD to Revise Certain Manufacturing Testing Limits for ANNOVERA® Business Wire
Dec-08-21 06:50AM	TherapeuticsMD Settles U.S. Patent Litigation with Amneal for BIJUVA® (Estradiol and Progesterone) Allowing for a May 25, 2032 Generic Entry Date Business Wire
Nov-24-21 07:54AM	TherapeuticsMD (NASDAQ:TXMD) investors are sitting on a loss of 90% if they invested five years ago Simply Wall St.
Nov-22-21 10:40AM	Therapeuticsmd Insider Trades $580K In Company Stock Benzinga
Nov-12-21 03:00AM	TherapeuticsMD, Inc. (TXMD) Q3 2021 Earnings Call Transcript Motley Fool
Nov-11-21 06:50AM	TherapeuticsMD Announces Third Quarter 2021 Financial Results Business Wire -7.82%
06:45AM	TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh ODowd, as Chief Executive Officer Business Wire
Nov-04-21 03:01PM	TherapeuticsMD (TXMD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-27-21 05:00PM	TherapeuticsMD to Report Third Quarter 2021 Results on November 11, 2021 Business Wire
Oct-15-21 05:33PM	TherapeuticsMD Announces Appointment of Mark Glickman as Chief Business Officer Business Wire
Oct-05-21 01:28PM	What Type Of Shareholders Own The Most Number of TherapeuticsMD, Inc. (NASDAQ:TXMD) Shares? Simply Wall St.
Oct-04-21 09:20AM	Where Do Hedge Funds Stand On TherapeuticsMD Inc (TXMD)? Insider Monkey
Sep-02-21 06:50AM	Therapeutics MD Is Urging Women to Take Pause During Menopause Awareness Month Business Wire +7.71%
Aug-23-21 06:50AM	TherapeuticsMD Announces Issuance of a J-Code for ANNOVERA® to Be Utilized in the Public Health Sector Business Wire +7.12%
Aug-19-21 08:01AM	5 Penny Stocks Insiders Are Buying Benzinga +5.53%
Aug-09-21 04:30PM	TherapeuticsMD Announces Appointment of Hugh ODowd as President Business Wire
Aug-04-21 08:05AM	TherapeuticsMD (TXMD) Reports Q2 Loss, Tops Revenue Estimates Zacks -6.66%
06:50AM	TherapeuticsMD Announces Second Quarter 2021 Financial Results Business Wire
Jul-28-21 03:03PM	Will TherapeuticsMD (TXMD) Report Negative Earnings Next Week? What You Should Know Zacks
Jul-26-21 06:50AM	TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021 Business Wire
Jul-06-21 11:49AM	10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman Insider Monkey
Jun-29-21 08:58AM	Breakeven On The Horizon For TherapeuticsMD, Inc. (NASDAQ:TXMD) Simply Wall St.
May-25-21 06:50AM	TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA Business Wire
May-24-21 07:00AM	The Sun Sentinel Names TherapeuticsMD, Inc. a Winner of the South Florida Top Workplaces 2021 Award Business Wire
May-07-21 01:31AM	TherapeuticsMD, Inc. (TXMD) Q1 2021 Earnings Call Transcript Motley Fool
May-06-21 10:56AM	TherapeuticsMD Shares Plunge On Declining Gross Margin, Total Prescription Volume Benzinga -13.28%
08:20AM	TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates Zacks
07:00AM	TherapeuticsMD Announces First Quarter 2021 Financial Results Business Wire
06:45AM	TherapeuticsMD, Inc. to Host Earnings Call ACCESSWIRE
May-03-21 07:00AM	TherapeuticsMD Announces Poster Presentation of ANNOVERA® Data at the American College of Obstetricians and Gynecologists 2021 Annual Meeting Business Wire
Apr-29-21 10:34AM	TherapeuticsMD's (NASDAQ:TXMD) Shareholders Are Down 85% On Their Shares Simply Wall St.
07:00AM	TherapeuticsMD to Report First Quarter 2021 Results on May 6, 2021 Business Wire
Apr-28-21 12:34PM	TherapeuticsMD (TXMD) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
Apr-09-21 11:16AM	TXMD Stock: The News Giving TherapeuticsMD Shares a Shot in the Arm Friday InvestorPlace
05:05AM	TherapeuticsMD's Hormone Therapy Approved in U.K. and Belgium TheStreet.com
Apr-08-21 04:05PM	TherapeuticsMD and Theramex Announce the Approval of BIJUVE® Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA® in Belgium Business Wire
Mar-15-21 10:32AM	Here's What TherapeuticsMD, Inc.'s (NASDAQ:TXMD) Shareholder Ownership Structure Looks Like Simply Wall St.
Mar-02-21 07:00PM	TherapeuticsMD, Inc. (TXMD) Q4 2020 Earnings Call Transcript Motley Fool
08:25AM	TherapeuticsMD (TXMD) Reports Q4 Loss, Tops Revenue Estimates Zacks
07:22AM	Recap: TherapeuticsMD Q4 Earnings Benzinga
07:00AM	TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results Business Wire
06:30AM	TherapeuticsMD, Inc. to Host Earnings Call ACCESSWIRE
Mar-01-21 10:05AM	TherapeuticsMD Earnings Preview Benzinga
07:00AM	TherapeuticsMD Announces Participation in Upcoming Investor Conferences Business Wire
Feb-23-21 04:05PM	TherapeuticsMD to Report Fourth Quarter 2020 Results on March 2, 2021 Business Wire
Feb-18-21 10:16AM	Here are the tough questions Congress needs to ask about GameStop today Yahoo Finance Video -5.41%
Feb-16-21 04:01PM	TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock Business Wire
12:02PM	What the GameStop Congressional hearing will reveal to retail investors Yahoo Finance
Feb-11-21 09:02AM	TherapeuticsMD Announces Pricing of $110 Million Public Offering of Common Stock Business Wire -11.52%
Feb-10-21 04:01PM	TherapeuticsMD Announces Underwritten Public Offering of its Common Stock Business Wire -14.90%
Feb-03-21 12:50PM	Is TherapeuticsMD (TXMD) Stock a Buy For 2021? Insider Monkey
Jan-29-21 03:29AM	TherapeuticsMD, Inc. (NASDAQ:TXMD) Analysts Just Cut Their EPS Forecasts Substantially Simply Wall St.
Jan-12-21 08:34AM	TherapeuticsMD (TXMD) Surges: Stock Moves 6.8% Higher Zacks
Dec-29-20 07:00AM	TherapeuticsMD Announces Participation in Upcoming Investor Conferences Business Wire
Dec-17-20 03:47AM	When Can We Expect A Profit From TherapeuticsMD, Inc. (NASDAQ:TXMD)? Simply Wall St.
Dec-15-20 08:13AM	Comedian Whitney Cummings Partners with TherapeuticsMD to Launch "Just Say Vagina" Business Wire +6.09%
Dec-11-20 10:34AM	Is TXMD A Good Stock To Buy Now? Insider Monkey
Nov-13-20 04:05PM	TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock Business Wire
07:00AM	TherapeuticsMD Announces Participation in the Stifel 2020 Virtual Healthcare Conference Business Wire
Nov-11-20 12:29PM	Analyst Estimates: Here's What Brokers Think Of TherapeuticsMD, Inc. (NASDAQ:TXMD) After Its Third-Quarter Report Simply Wall St.
Nov-10-20 08:58AM	TherapeuticsMD Announces Pricing of $30 Million Public Offering of Common Stock Business Wire -11.18%
Nov-09-20 04:01PM	TherapeuticsMD Announces Underwritten Public Offering of its Common Stock Business Wire +24.59%
03:00PM	TherapeuticsMD, Inc. (TXMD) Q3 2020 Earnings Call Transcript Motley Fool
08:15AM	TherapeuticsMD (TXMD) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:28AM	TherapeuticsMD: Q3 Earnings Insights Benzinga
06:55AM	TherapeuticsMD® Announces Third Quarter 2020 Financial Results Business Wire
06:30AM	TherapeuticsMD, Inc. to Host Earnings Call ACCESSWIRE
Nov-02-20 12:31PM	Analysts Estimate TherapeuticsMD (TXMD) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-29-20 07:00AM	TherapeuticsMD to Report Third Quarter 2020 Results on November 9, 2020 Business Wire
Oct-28-20 12:33PM	Earnings Preview: TherapeuticsMD (TXMD) Q3 Earnings Expected to Decline Zacks
Oct-26-20 04:05PM	POPSUGAR Launches New Womens Health Destination, "Full Disclosure," in Collaboration With TherapeuticsMD Business Wire
10:01AM	ROCE Insights For TherapeuticsMD Benzinga
Oct-22-20 01:16PM	Should You Take Comfort From Insider Transactions At TherapeuticsMD, Inc. (NASDAQ:TXMD)? Simply Wall St.
Oct-09-20 08:00AM	TherapeuticsMD Supports the Importance of Empowering Women to Make Informed Choices about their Sexual and Reproductive Health Business Wire -6.25%
Oct-07-20 08:43AM	Implied Volatility Surging for TherapeuticsMD (TXMD) Stock Options Zacks
Oct-06-20 10:03AM	Looking Into TherapeuticsMD's Return On Capital Employed Benzinga
Oct-02-20 10:17AM	Return On Capital Employed Overview: TherapeuticsMD Benzinga
Sep-25-20 09:02AM	TherapeuticsMD Provides Update on Third Quarter Progress Business Wire +7.63%
Sep-21-20 05:01PM	Knight and TherapeuticsMD Announce Health Canada Approval of BIJUVA® GlobeNewswire

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Donegan Michael C	CAO and VP of Finance	Nov 30	Sale	0.54	29,790	15,947	99,368	Dec 02 06:30 AM
Collins Cooper C.	Director	Nov 18	Buy	0.58	1,000,000	578,500	2,236,864	Nov 22 06:30 AM
Collins Cooper C.	Director	Aug 18	Buy	0.72	900,000	648,000	1,236,864	Aug 19 06:01 AM
Collins Cooper C.	Director	Aug 17	Buy	0.77	100,000	77,000	336,864	Aug 19 06:01 AM
Ling Karen	Director	Aug 17	Buy	0.75	33,445	25,084	130,309	Aug 19 04:31 PM
BISARO PAUL	Director	Aug 16	Buy	0.79	50,000	39,500	196,864	Aug 18 06:03 AM
Thompson Tommy G	Director	Aug 13	Buy	0.87	11,000	9,570	715,600	Aug 17 06:47 AM
DArecca James	Chief Financial Officer	Aug 12	Sale	0.87	93,337	81,203	123,830	Aug 12 09:33 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience